Zhu J Z, Chen S L, Cui Z C
Department of Internal Medicine, Beijing Red Cross Chao Yang Hospital.
Zhonghua Nei Ke Za Zhi. 1991 Dec;30(12):746-8, 789.
Antithrombin III level in the plasma of patients with AMI was determined dynamically by using the methods of chromogenic substrate and rocket electrophoresis. Meanwhile, plasma specimens of 40 normal subjects were examined with the same method. The results showed that the AT III level in AMI patients was much lower than that in normal controls at the first and third day after infarction. The level was also significantly lower than that at the 7th, 14th and 21st day after the onset of the disease. It revealed that there was a hypercoagulative state in patients within the first three days of infarction. The AT III level in patients who died within ten days was much lower than that in the survivor group, P less than 0.01. The authors concluded that a patient may be in a severe condition when their plasma AT III levels decrease apparently and persistently.
采用发色底物法和火箭电泳法动态检测急性心肌梗死(AMI)患者血浆抗凝血酶III(AT III)水平。同时,用相同方法检测40例正常受试者的血浆标本。结果显示,AMI患者在梗死发生后的第1天和第3天,其AT III水平明显低于正常对照组。该水平也显著低于发病后第7天、第14天和第21天的水平。这表明梗死发生后的前三天患者处于高凝状态。在十天内死亡的患者其AT III水平远低于存活组,P<0.01。作者得出结论,当患者血浆AT III水平明显且持续下降时,病情可能较重。